Brokerage Firm Rating Update on Allergan plc. (AGN)

Allergan plc. (AGN) : Zacks Investment Research ranks Allergan plc. (AGN) as 3, which is a Hold recommendation. 9 research analysts consider that the stocks fundamentals point to a bright future, hence they rate the stock as a Strong Buy. 3 other analysts are mildly bullish on the stock and favor a Buy. A total of 3 analysts believe that the stock has a limited upside, hence they advise a Hold. The average broker rating of 15 research analysts is 1.57, which indicates as a Buy.

Allergan plc. (AGN) : The most positive equity analysts on Allergan plc. (AGN) expects the shares to touch $400, whereas, the least positive believes that the stock will trade at $227 in the short term. The company is covered by 11 Wall Street Brokerage Firms. The average price target for shares are $295.73 with an expected fluctuation of $42.1 from the mean.


For the current week, the company shares have a recommendation consensus of Buy. Also, Equity Analysts at the Brokerage Firm, Mizuho Securities, upgrades their rating on the shares of Allergan plc. (NYSE:AGN). Mizuho Securities has a Buy rating on the shares. Previously, the analysts had a Neutral rating on the shares. The rating by the firm was issued on August 19, 2016.

Allergan plc. (NYSE:AGN): stock was range-bound between the intraday low of $236.04 and the intraday high of $241.495 after having opened at $239.12 on Wednesdays session. The stock finally closed in the red at $239.12, a loss of -0.29%. The stock remained in the red for the whole trading day. The total traded volume was 2,317,325 shares. The stock failed to cross $241.495 in Wednesdays trading. The stocks closing price on Thursday was $239.12.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.